SHL Telemedicine Ltd. (SHLT)
NASDAQ: SHLT · IEX Real-Time Price · USD
5.31
-0.04 (-0.75%)
Jul 2, 2024, 3:57 PM EDT - Market closed
SHL Telemedicine Revenue
In the year 2023, SHL Telemedicine had annual revenue of $57.08M, a decrease of -3.26%.
Revenue (ttm)
$57.08M
Revenue Growth
-3.26%
P/S Ratio
1.46
Revenue / Employee
$97,899
Employees
583
Market Cap
83.43M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 57.08M | -1.92M | -3.26% |
| Dec 31, 2022 | 59.00M | 9.42M | 18.99% |
| Dec 31, 2021 | 49.58M | 9.42M | 23.45% |
| Dec 31, 2020 | 40.16M | -1.72M | -4.11% |
| Dec 31, 2019 | 41.88M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PetMed Express | 281.06M |
| Protalix BioTherapeutics | 59.65M |
| Eton Pharmaceuticals | 35.30M |
| Forian | 20.49M |
| Affimed | 4.26M |
SHLT News
- 12 days ago - SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity - Business Wire
- 6 weeks ago - SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test - Business Wire
- 6 weeks ago - SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch - Business Wire
- 2 months ago - SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones - Business Wire
- 2 months ago - Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine's SmartHeart® in Post-ACS Patient Care - Business Wire
- 3 months ago - SHL Telemedicine's SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment - Business Wire
- 3 months ago - SHL Telemedicine: Invitation to Conference Call Presenting Annual Results 2023 - Business Wire
- 3 months ago - SHL Telemedicine Receives Buy Rating with $11.00 Price Target - Business Wire